Grigorios Kyriazis Urology Care Limited - Accounts to registrar (filleted)

REGISTERED NUMBER: 15437856 (England and Wales)

Unaudited Financial Statements for the Year Ended 31 January 2026

for

Grigorios Kyriazis Urology Care Limited

Page

Balance Sheet

1

Notes to the Financial Statements

3

FIXED ASSETS

Tangible assets

4

3,217

649

CURRENT ASSETS

Cash at bank

7,788

1,252

CREDITORS

Amounts falling due within one year

5

3,726

1,460

NET CURRENT ASSETS/(LIABILITIES)

4,062

(208

)

TOTAL ASSETS LESS CURRENT
LIABILITIES

7,279

441

CREDITORS

Amounts falling due after more than one
year

6

-

(100

)

PROVISIONS FOR LIABILITIES

8

(611

)

(123

)

NET ASSETS

6,668

218

CAPITAL AND RESERVES

Called up share capital

9

101

Retained earnings

6,567

117

SHAREHOLDERS' FUNDS

6,668

218

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 January 2026.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 January 2026 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the director and authorised for issue on 19 May 2026 and were signed by:

Dr G Kyriazis - Director

1.	STATUTORY INFORMATION

Grigorios Kyriazis Urology Care Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number:

15437856

Registered office:

C/o Echo Tax Spaces, Manchester

Peter House, Oxford Street

Manchester

United Kingdom

M1 5AN

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Fixtures and fittings

-

20% on cost

Computer equipment

-

25% on cost

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits

The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2025 - 1 ) .

4.	TANGIBLE FIXED ASSETS

Fixtures

and

Computer

fittings

equipment

Totals

£

COST

At 1 February 2025

-

799

Additions

2,334

603

2,937

At 31 January 2026

2,334

1,402

3,736

DEPRECIATION

At 1 February 2025

-

150

Charge for year

61

308

369

At 31 January 2026

61

458

519

NET BOOK VALUE

At 31 January 2026

2,273

944

3,217

At 31 January 2025

-

649

5.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

31.1.26

31.1.25

£

Bank loans and overdrafts (see note 7)

-

79

Other loans (see note 7)

100

399

Tax

2,784

373

Credit card

360

-

Directors' current accounts

2

129

Accrued expenses

480

3,726

1,460

6.

CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR

31.1.26

31.1.25

£

Other loans (see note 7)

-

100

7.

LOANS

An analysis of the maturity of loans is given below:

31.1.26

31.1.25

£

Amounts falling due within one year or on demand:

Bank overdrafts

-

79

Other loans

100

399

100

478

Amounts falling due between one and two years:

Other loans - 1-2 years

-

100

8.	PROVISIONS FOR LIABILITIES

31.1.26

31.1.25

£

Deferred tax

611

123

Deferred

tax

£

Balance at 1 February 2025

123

Provided during year

488

Balance at 31 January 2026

611

9.	CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:

Number:

Class:

Nominal

31.1.26

31.1.25

value:

£

100

Ordinary A

£1

100

1

Ordinary B

£1

1

101

10.	DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the year ended 31 January 2026 and the period ended 31 January 2025:

31.1.26

31.1.25

£

Dr G Kyriazis

Balance outstanding at start of year

(129

)

-

Amounts advanced

8,190

3,013

Amounts repaid

(8,064

)

(3,142

)

Amounts written off

-

Amounts waived

-

Balance outstanding at end of year

(3

)

(129

)

11.	ULTIMATE CONTROLLING PARTY

The controlling party is Dr G Kyriazis.